Free shipping on all orders over $ 500

Vamorolone

Cat. No. M21092
Vamorolone Structure
Synonym:

VBP15

Size Price Availability Quantity
5mg USD 55  USD55 In stock
10mg USD 100  USD100 In stock
25mg USD 180  USD180 In stock
50mg USD 280  USD280 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vamorolone (VBP15) is the first orally active dissociative steroidal anti-inflammatory and membrane stabilizer. vamorolone improves myotonic dystrophy without side effects. vamorolone inhibits (NF-κB) inhibition and reduces the effects of hormones.

Chemical Information
Molecular Weight 356.46
Formula C22H28O4
CAS Number 13209-41-1
Form Solid
Solubility (25°C) DMSO : 62.5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Michela Guglieri, et al. JAMA Neurol. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

[2] Jean K Mah, et al. JAMA Netw Open. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial

[3] Edward C Smith, et al. PLoS Med. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

[4] Eric P Hoffman, et al. Neurology. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

[5] Christopher R Heier, et al. Life Sci Alliance. Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy

Related GCR Products
ORIC-101

ORIC-101 is a potent and selective glucocorticoid receptor antagonist with an EC50 value of 5.6 nM and anticancer activity.

Mometasone Furoate Monohydrate

Mometasone Furoate Monohydrate is a glucocorticoid receptor agonist with anti-inflammatory and anti-allergic activity.

RU 26988

RU 26988 is a highly specific glucocorticoid receptor agonist.

HP210

HP210 is a selective glucocorticoid receptor modulator (SGRM).

Glucocorticoid receptor modulator 2

Glucocorticoid receptor modulator 2 is a glucocorticoid receptor modulator, with an IC50 value less than 100 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vamorolone, VBP15 supplier, GCR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.